Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2885-2890

  Schrump, David S ^a   Matthews, Wilbert ^a   Chen, G Aaron ^a   Mixon, Arnold ^a   Altorki, Nasser K ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CYCLIN D1; FLAVOPIRIDOL; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ESOPHAGUS CARCINOMA; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; ESOPHAGEAL NEOPLASMS; FLAVONOIDS; HUMANS; PIPERIDINES; TUMOR CELLS, CULTURED;

EID: 0031725137     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Altorki, N. K., Oliveria, S., and Schrump, D. S. The epidemiology and molecular biology of Barrett's adenocarcinoma. Semin. Oncol., 13: 270-280, 1997.
2. Reid, B. J., Barrett, M. T., Galipeau, P. C., Sanchez, C. A., Neshat, K., Cowan, D. S., and Levine, D. S. Barrett's esophagus: ordering the events that lead to cancer. Eur. J. Cancer Prev., 5: 57-65, 1996.
3. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
4. Grana, X., and Reddy, E. P. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11: 211-219, 1995.
5. Boynton, R. F., Huang, Y., Blount, P. L., Reid, B. J., Raskind, W. H., Haggitt, R. C., Newkirk, C., Resau, J. H., Yin, J., McDaniel, T., and Meltzer, S. J. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res., 51: 5766-5769, 1991.
6. Huang, Y., Boynton, R. F., Blount, P. L., Silverstein, R. J., Yin, J., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophaseal cancers. Cancer Res., 52: 6525-6530, 1992.
7. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y-J., Lu, S-H., and Weinstein, I. B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52: 2980-2983, 1992.
8. Montesano, R., Hollstein, M., and Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69: 225-235, 1996.
9. INK4. Cancer Gene Ther., 3: 357-364, 1996.
10. INK4 proteins is restricted to the subset of lung cancer lines that retains wild-type RB. Oncogene, 9: 3375-3378, 1994.
11. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct subsets of human cancer cell lines. Int. J. Cancer, 61: 115-120, 1995.
12. Zhou, P., Jiang, W., Zhang, Y. J., Kahn, S. M., Schieren, I., Santella, R. M. and Weinstein, I. B. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene, 11: 571-580, 1995.
13. Sedlacek, H. H., Czech, J., Naik, R., Kaur, G., Worland, P., Losiewicz, M., Parker, B., Carlson, B., Smith, A., Senderowicz, A., and Sausville, E. Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. Int. J. Oncol., 9: 1143, 1996.
14. 1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
15. Filgueira-De-Azevedo, W., Muller-Dieckmann, H-J., Schulze-Gahmen, U., Worland, P. J., Sausville, E. A., and Kim, S-H. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA, 93: 2735, 1996.
16. König, A., Schwartz, G. K., Muhammad, R. M., Al-Katib, A., and Gabrilove, J. L. The novel cyclin-dependent kinase inhibitor flavopiridol down-regulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. Blood, 90: 4307-4312, 1997.
17. Czech, J., Hoffmann, D., Naik, R., and Sedlacek, H-H. Antitumoral activity of flavone L86-8275. Int. J. Oncol., 6: 31-36, 1995.
18. Zhou, Q., Stetler-Stevenson, M., and Steeg, P. S. Inhibition of cyclin D expression in human beast carcinoma cells by retinoids in vitro. Oncogene, 15: 107-115, 1997.
19. Altorki, N., Schwartz, G. K., Blundell, M., Davis, B. M., Kelsen, D. P., and Albino, A. P. Characterization of cell lines established from human sastric-esophageal adenocarcinomas: biologic phenotype and invasion potential. Cancer (Phila.), 72: 649-657, 1993.
20. Liu, X-M., Lotan, R., El-Naggar, A. K., Schrump, D. S., Tahara, E., and Xu, X-C. Expression of nuclear retinoid receptors and differentiation markers in human esophageal carcinoma cells and their modulation by retinoids. Proc. Am. Assoc. Cancer Res., 38: 454, 1997.
21. Andreeff, M., Darzynkiewicz, Z., Sharpless, T. K., Clarkson, B. D., and Melamed, M. R. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood, 55: 282-293, 1980.
22. Krishan, A. Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188-193, 1975.
23. INK4 in human cancer. Proc. Natl. Acad. Sci. USA, 91: 11045-11049, 1994.
24. Arber, N., Lightdale, C., Rotterdam, H., Han, E. K. H., Sgambato, A., Yap, E., Ahsan, H., Finegold, J., Stevens, P. D., Green, P. H. R., Hibshoosh, H., Neugut, A. I., Holt, P. R., and Weinstein, I. B. Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol. Biomark. Prev., 5: 457-459, 1996.
25. Kelsen, D., Laufer, I., Leichman, L., Orringer, M. B., Rich, T. A., and Scherl, E. Alarming trends in esophageal cancer. Patient Care, 15: 72-122, 1992.
26. Reid, B. J., Blount, P. L., Rubin, C. E., Levine, D. S., Haggitt, R. C., and Rabinovitch, P. S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopie surveillance of a cohort. Gastroenterology, 102: 1212-1219, 1992.
27. Chanvitan, A., Puttawibul, P., and Casson, A. G. Flow cytometry in squamous cell esophageal cancer and precancerous lesions. Dis. Esophagus, 10: 206-210, 1997.
28. Blount, P. L., Meltzer, S. J., Yin, J., Huang, Y., Krasna, M. J., and Reid, B. J. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl. Acad. Sci. USA, 90: 3221-3225, 1993.
29. Barrett, M. T., Galipeau, P. C., Sanchez, C. A., Emond, M. J., and Reid, B. J. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene, 12: 1873-1878, 1996.
30. Barrett, M. T., Sanchez, C. A., Galipeau, P. C., Neshat, K., Emond, M., and Reid, B. J. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrrett's esophagus. Oncogene, 13: 1867-1873, 1996.
31. Nakagawa, H., Wang, T. C., Zukerberg, L., Odze, R., Togawa, K., May, G. H. W., Wilson, J., and Rustgi, A. K. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene, 14: 1185-1190, 1997.
32. Bible, K. C., and Kaufmann, S. H. Flavopiridol, a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. Cancer Res., 56: 4856-4861, 1996.
33. Parker, B. W., Kaur, G., Nieves-Neira, W., Taimi, M., Kohlhagen, G., Shimizu, T., Losiewicz, M. D., Pommier, Y., Sausville, E. A., and Senderowicz, A. M. Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood, 91: 458-465, 1998.
34. Jones, D. L., Thompson, D. A., and Munger, K. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7 induced apoptosis. Virology, 239: 97-107, 1997.
35. Samuelson, A. V., and Lowe, S. W. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl. Acad. Sci. USA, 94: 12094-12099, 1997.
36. Berry, D. E., Lu, Y., Schmidt, B., Fallon, P. G., O'Connell, C., Hu, S-X., Xu, H-J., and Blanck, G. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene, 12: 1809-1819, 1996.
37. Ishii, H., Igarashi, T., Saito, T., Nakano, T., Mori, M., Ohyama, H., Miyamoto, T., Saito, Y., and Oh, H. Retinoblastoma protein expressed in human non-Hodgkin's lymphoma cells generates resistance against radiation-induced apoptosis. Am. J. Hematol., 55: 46-48, 1997.
38. Shimizu, E., Coxon, A., Otterson, G. A., Steinberg, S. M., Kratzke, R. A., Kim, Y. W., Fedorko, J., Oie, H., Johnson, B. E., Mulshine, J. L., Minna, J. D., Gazdar, A. F., and Kaye, F. J. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene, 9: 2441-2448, 1994.
39. 1 checkpoint. Mol. Cell. Biol., 16: 17-25, 1996.
40. Filmus, J., Robles, A. I., Shi, W., Wong, M. J., Colombo, L.. L., and Conti, C. J. Induction of cyclin D1 overexpression by activated ras. Oncogene, 9: 3627-3633, 1994.
41. Sofer-Levi, Y., and Resnitzky, D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene, 13: 2431-2437, 1996.
42. Tiemann, F., and Hinds, P. W. Induction of DNA synthesis and apoptosis by resulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J., 17: 1040-1052, 1998.
43. Fang, X. J., Jin, X. M., Xu, H. J., Liu, L., Peng, H. Q., Hogg, D., Roth, J. A., Yu, Y. H., Xu, F. J., Bast, R. C., and Mills, G. B. Expression of p16 induces transcriptional down-regulation of the RB gene. Oncogene, 16: 1-8, 1998.
44. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med., 3: 313-319, 1997.
45. Driscoll, B., Wu, L., Buckley, S., Hall, F. L., Anderson, K. D., and Warburton, D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol., 17: L941-L949, 1997.